6630--Cepheid GeneXpert Xpress Systems - Notice of Intent to Sole Source

Special Notice Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36C25020Q0755
Agency
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

This Special Notice announces the Department of Veterans Affairs' intent to enter a sole source contract with Cepheid. The agency plans to award a firm-fixed price purchase order to Cepheid for GeneXpert Xpress systems to be used at the Louis Stokes Cleveland VA Medical Center and surrounding clinics.

The Special Notice seeks 15 GeneXpert Xpress II systems and one GeneXpert Xpress IV system for rapid PCR testing of influenza A/B and strep throat. Interested parties have until June 18, 2020 to provide evidence that competition would be advantageous, with responses submitted to the identified contracting officer via email. The systems must be CLIA waived and capable of performing two tests simultaneously. This acquisition will enable all Cleveland area VA laboratories to use the same test kits and eliminate separate contracts.

Notice text

INTENT TO SOLE SOURCE

The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement pursuant to FAR 6.302-1, for GeneXpert Xpress Systems for the Louis Stokes Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106. The Department of Veterans Affairs intends to award a sole source, firm-fixed price purchase order to Cepheid, 904 Caribbean Drive, Sunnyvale, CA 94089. The associated North American Industry Classification System (NAICS) Code is 334516 Analytical Laboratory Instrument Manufacturing, and the Business Size Standard is 1,000 Employees.

The proposed procurement if for fifteen (15) GeneXpert Xpress II systems (Model #GXII-CLIA-L) and one (1) GeneXpert Xpress IV system (Model #GXIV-CLIA-L). These instruments will be used for the PCR rapid testing of influenza A/B and strep throat for use at the Wade Park Campus and the surrounding outpatient clinics. The testing instruments must be Clinical Laboratory Improvement Amendments (CLIA) waived due to licensing requirements for the outpatient clinics. The instruments must also be capable of performing 2 tests at once and perform rapid Strep A testing, which eliminates the need for another testing kit. The main lab at the Wade Park Campus currently uses Cepheid instrumentation to a much larger scale with a greater variety of testing platforms. The test kits used on the current instrumentation are compatible with the smaller instruments being ordered for the outpatient clinics. The acquisition of GeneXpert instruments for the surrounding outpatient laboratories will enable all Cleveland area VA laboratory facilities to utilize the same test kits, eliminating the need for separate test kit contracts.

It is the Government s belief that Cepheid s GeneXpert systems are manufactured solely for Cepheid, and Cepheid is the sole authorized distributor of GeneXpert systems in the acute care market within the United States.

This notice satisfies the requirement at FAR 5.201(b)(1), to publicize the proposed contract action. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Interested persons may identify their interests and capability to respond to this requirement no later than 11:59 PM Eastern Time, Thursday, June 18, 2020. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government.

Interest/capability statements shall be submitted to Jeffrey Rozema via e-mail at jeffrey.rozema@va.gov. Telephone inquiries will not be accepted.

Files

File Type Posted
36C25020Q0755.docx DOCX document

Notice history

Notice Type Posted
6630--Cepheid GeneXpert Systems Latest Limited / Sole Source Justification
6630--Cepheid GeneXpert Systems Award Award Notice
This notice Latest special notice Special Notice

Similar open opportunities

Opportunity Agency Set-aside Responses due
6550--Cepheid GeneXpert Testing Supplies Beckley Vamc Clarksburg Vamc Vamhcs Washington Vamc · NAICS 325413 Veterans Integrated Service Network 5 No set-aside
6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ Department of Veterans Affairs VA North Atlantic Health Network HSA 1.3 Various Locations, United States · NAICS 325413 Veterans Integrated Service Network 5 No set-aside
6515--Notice of Intent to Award Sole Source - TEE PROBE TRANSDUCER NAICS 334510 Veterans Integrated Service Network 2 No set-aside
FRESNO- Radiology X-Ray System PM Services NAICS 811210 Veterans Integrated Service Network 21 No set-aside
Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC Seattle, Washington 98108, United States · NAICS 325413 Veterans Integrated Service Network 20 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors